Pitiriga, V.C.; Papamentzelopoulou, M.; Nikoloudis, D.; Saldari, C.; Konstantinakou, K.E.; Vasileiou, I.V.; Tsakris, A.
Evaluating SARS-CoV-2 T Cell Immunity in COVID-19-Naive Vaccinated Individuals with and Without Spike Protein IgG Antibodies. Pathogens 2025, 14, 415.
https://doi.org/10.3390/pathogens14050415
AMA Style
Pitiriga VC, Papamentzelopoulou M, Nikoloudis D, Saldari C, Konstantinakou KE, Vasileiou IV, Tsakris A.
Evaluating SARS-CoV-2 T Cell Immunity in COVID-19-Naive Vaccinated Individuals with and Without Spike Protein IgG Antibodies. Pathogens. 2025; 14(5):415.
https://doi.org/10.3390/pathogens14050415
Chicago/Turabian Style
Pitiriga, Vassiliki C., Myrto Papamentzelopoulou, Dimitris Nikoloudis, Chrysa Saldari, Kanella E. Konstantinakou, Irene V. Vasileiou, and Athanasios Tsakris.
2025. "Evaluating SARS-CoV-2 T Cell Immunity in COVID-19-Naive Vaccinated Individuals with and Without Spike Protein IgG Antibodies" Pathogens 14, no. 5: 415.
https://doi.org/10.3390/pathogens14050415
APA Style
Pitiriga, V. C., Papamentzelopoulou, M., Nikoloudis, D., Saldari, C., Konstantinakou, K. E., Vasileiou, I. V., & Tsakris, A.
(2025). Evaluating SARS-CoV-2 T Cell Immunity in COVID-19-Naive Vaccinated Individuals with and Without Spike Protein IgG Antibodies. Pathogens, 14(5), 415.
https://doi.org/10.3390/pathogens14050415
